• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p38α通过拮抗JNK-c-Jun信号通路抑制正常细胞和癌细胞的增殖。

p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway.

作者信息

Hui Lijian, Bakiri Latifa, Mairhorfer Andreas, Schweifer Norbert, Haslinger Christian, Kenner Lukas, Komnenovic Vukoslav, Scheuch Harald, Beug Hartmut, Wagner Erwin F

机构信息

Research Institute of Molecular Pathology, A-1030 Vienna, Austria.

出版信息

Nat Genet. 2007 Jun;39(6):741-9. doi: 10.1038/ng2033. Epub 2007 Apr 29.

DOI:10.1038/ng2033
PMID:17468757
Abstract

The mitogen-activated protein kinase (MAPK) p38alpha controls inflammatory responses and cell proliferation. Using mice carrying conditional Mapk14 (also known as p38alpha) alleles, we investigated its function in postnatal development and tumorigenesis. When we specifically deleted Mapk14 in the mouse embryo, fetuses developed to term but died shortly after birth, probably owing to lung dysfunction. Fetal hematopoietic cells and embryonic fibroblasts deficient in p38alpha showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway. Notably, in chemical-induced liver cancer development, mice with liver-specific deletion of Mapk14 showed enhanced hepatocyte proliferation and tumor development that correlated with upregulation of the JNK-c-Jun pathway. Furthermore, inactivation of JNK or c-Jun suppressed the increased proliferation of Mapk14-deficient hepatocytes and tumor cells. These results demonstrate a new mechanism whereby p38alpha negatively regulates cell proliferation by antagonizing the JNK-c-Jun pathway in multiple cell types and in liver cancer development.

摘要

丝裂原活化蛋白激酶(MAPK)p38α控制炎症反应和细胞增殖。我们利用携带条件性Mapk14(也称为p38α)等位基因的小鼠,研究了其在出生后发育和肿瘤发生中的功能。当我们在小鼠胚胎中特异性删除Mapk14时,胎儿能够足月发育,但出生后不久死亡,可能是由于肺功能障碍。缺乏p38α的胎儿造血细胞和胚胎成纤维细胞由于c-Jun氨基末端激酶(JNK)-c-Jun途径的持续激活而显示出增殖增加。值得注意的是,在化学诱导的肝癌发生过程中,肝脏特异性删除Mapk14的小鼠表现出增强的肝细胞增殖和肿瘤发展,这与JNK-c-Jun途径的上调相关。此外,JNK或c-Jun的失活抑制了Mapk14缺陷型肝细胞和肿瘤细胞的增殖增加。这些结果证明了一种新机制,即p38α通过在多种细胞类型和肝癌发生过程中拮抗JNK-c-Jun途径来负向调节细胞增殖。

相似文献

1
p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway.p38α通过拮抗JNK-c-Jun信号通路抑制正常细胞和癌细胞的增殖。
Nat Genet. 2007 Jun;39(6):741-9. doi: 10.1038/ng2033. Epub 2007 Apr 29.
2
p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation.p38α丝裂原活化蛋白激酶在肺干细胞和祖细胞的增殖与分化中至关重要。
Nat Genet. 2007 Jun;39(6):750-8. doi: 10.1038/ng2037. Epub 2007 Apr 29.
3
p38alpha: a suppressor of cell proliferation and tumorigenesis.p38α:细胞增殖和肿瘤发生的抑制因子。
Cell Cycle. 2007 Oct 15;6(20):2429-33. doi: 10.4161/cc.6.20.4774. Epub 2007 Oct 21.
4
A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.p27Kip1的一种新的肿瘤抑制机制:通过抑制JNK/c-Jun途径介导的表皮生长因子受体(EGFR)下调。
Biochem J. 2014 Nov 1;463(3):383-92. doi: 10.1042/BJ20140103.
5
The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.Ras/Rac1/Cdc42/SEK/JNK/c-Jun信号级联反应是激动剂刺激大鼠原代肝细胞培养物中DNA合成的关键途径。
Mol Biol Cell. 1998 Mar;9(3):561-73. doi: 10.1091/mbc.9.3.561.
6
JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.JNK/c-Jun信号传导介导了RANKL在破骨细胞中的抗凋亡作用。
J Bone Miner Res. 2008 Jun;23(6):907-14. doi: 10.1359/jbmr.080211.
7
c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.c-Jun氨基末端激酶在非小细胞肺癌中被激活,并促进人支气管上皮细胞的肿瘤转化。
Oncogene. 2007 Apr 19;26(18):2658-66. doi: 10.1038/sj.onc.1210050. Epub 2006 Oct 23.
8
JNK signalling modulates intestinal homeostasis and tumourigenesis in mice.JNK信号通路调节小鼠肠道内环境稳定和肿瘤发生。
EMBO J. 2009 Jul 8;28(13):1843-54. doi: 10.1038/emboj.2009.153. Epub 2009 Jun 11.
9
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.c-Jun/AP-1通过抑制p53/p21和p38丝裂原活化蛋白激酶(MAPK)活性来控制肝脏再生。
Genes Dev. 2006 Aug 15;20(16):2306-14. doi: 10.1101/gad.390506.
10
SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis.丝裂原活化蛋白激酶激酶4(SEK1/MKK4)介导的应激激活蛋白激酶/应激活化蛋白激酶(SAPK/JNK)信号通路通过一条不同于核因子κB(NF-κB)诱导的抗凋亡途径参与胚胎肝母细胞的增殖。
Dev Biol. 2002 Oct 15;250(2):332-47.

引用本文的文献

1
Synergistic roles of NFATc1 and c-Jun in immunomodulation.NFATc1和c-Jun在免疫调节中的协同作用。
Biochem Biophys Rep. 2025 Jul 7;43:102137. doi: 10.1016/j.bbrep.2025.102137. eCollection 2025 Sep.
2
KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression.KDM5D组蛋白去甲基化酶通过其酶活性介导p38α失活,从而抑制癌症进展。
Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2402022121. doi: 10.1073/pnas.2402022121. Epub 2024 Dec 5.
3
Remodeling p38 signaling in muscle controls locomotor activity via IL-15.
重塑肌肉中的 p38 信号通路通过 IL-15 控制运动活动。
Sci Adv. 2024 Aug 16;10(33):eadn5993. doi: 10.1126/sciadv.adn5993. Epub 2024 Aug 14.
4
Shank3 deficiency elicits autistic-like behaviors by activating p38α in hypothalamic AgRP neurons.Shank3 缺失通过激活下丘脑 AgRP 神经元中的 p38α 引发自闭症样行为。
Mol Autism. 2024 Apr 3;15(1):14. doi: 10.1186/s13229-024-00595-4.
5
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma.异常的非经典 NF-κB 信号转导重新编程表观基因组景观,以驱动多发性骨髓瘤中的致癌转录组。
Nat Commun. 2024 Mar 21;15(1):2513. doi: 10.1038/s41467-024-46728-4.
6
Tracheal agenesis versus tracheal atresia: anatomical conditions, pathomechanisms and causes with a possible link to a novel MAPK11 variant in one case.气管发育不全与气管闭锁:解剖条件、发病机制和病因,一例可能与新型 MAPK11 变异有关。
Orphanet J Rare Dis. 2024 Mar 12;19(1):114. doi: 10.1186/s13023-024-03106-z.
7
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer.ASK1/p38 轴抑制可阻止肝细胞释放线粒体“危险信号”,并抑制其向肝硬化和肝癌的进展。
Hepatology. 2024 Aug 1;80(2):346-362. doi: 10.1097/HEP.0000000000000801. Epub 2024 Feb 20.
8
p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy.下一代多发性骨髓瘤治疗的p38分子靶向治疗
Cancers (Basel). 2024 Jan 6;16(2):256. doi: 10.3390/cancers16020256.
9
RvD1 improves resident alveolar macrophage self-renewal via the ALX/MAPK14/S100A8/A9 pathway in acute respiratory distress syndrome.在急性呼吸窘迫综合征中,RvD1通过ALX/MAPK14/S100A8/A9途径改善驻留肺泡巨噬细胞的自我更新。
J Adv Res. 2025 Jan;67:289-299. doi: 10.1016/j.jare.2024.01.017. Epub 2024 Jan 17.
10
5-Methoxyisatin N(4)-Pyrrolidinyl Thiosemicarbazone (MeOIstPyrd) Restores Mutant p53 and Inhibits the Growth of Skin Cancer Cells, In Vitro.5-甲氧基异吲哚酮N(4)-吡咯烷基硫代半卡巴腙(MeOIstPyrd)可恢复突变型p53并在体外抑制皮肤癌细胞生长。
ACS Omega. 2023 Aug 24;8(35):31998-32016. doi: 10.1021/acsomega.3c03824. eCollection 2023 Sep 5.